Mark Purcell
Stock Analyst at Morgan Stanley
(0)
# 4391
Out of 5,231 analysts
5
Total ratings
50.00%
Success rate
-10.13%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Novartis | Initiates Coverage On: Equal-Weight | 114 | 103.11 | 10.56% | 1 | Jan 23, 2024 | |
Sanofi | Initiates Coverage On: Equal-Weight | 55 | 52.37 | 5.02% | 1 | Jan 23, 2024 | |
GSK | Initiates Coverage On: Equal-Weight | 44 | 35.07 | 25.46% | 1 | Jan 23, 2024 | |
AstraZeneca | Initiates Coverage On: Overweight | 85 | 70.28 | 20.94% | 1 | Jan 23, 2024 | |
Novo Nordisk | Initiates Coverage On: Overweight | 120 | 84.05 | 42.77% | 1 | Jan 23, 2024 |